US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 9.340
  • -0.110-1.16%
Close Nov 22 16:00 ET
  • 9.340
  • 0.0000.00%
Post 20:01 ET
638.64MMarket Cap-1627P/E (TTM)

Phathom Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.35M
7.32M
1.91M
682K
682K
0
0
0
0
0
Operating revenue
--16.35M
--7.32M
--1.91M
--682K
--682K
--0
--0
--0
--0
--0
Cost of revenue
2.36M
1.38M
426K
167K
167K
0
0
0
0
Gross profit
14M
5.95M
1.49M
515K
515K
0
0
0
0
Operating expense
137.79%84.79M
162.60%83.25M
137.52%71.44M
-2.68%167.83M
50.92%70.39M
-16.15%35.66M
-30.12%31.7M
-20.65%30.08M
27.66%172.44M
41.17%46.64M
Selling and administrative expenses
225.27%76.1M
300.65%75.87M
233.42%62.01M
16.76%117.93M
85.68%57M
-0.48%23.4M
-28.67%18.94M
-8.14%18.6M
60.98%101M
57.51%30.7M
Research and development costs
-29.11%8.69M
-42.21%7.38M
-17.85%9.43M
-30.15%49.9M
-16.00%13.39M
-35.53%12.26M
-32.16%12.76M
-35.00%11.48M
-1.24%71.44M
17.67%15.95M
Operating profit
-98.54%-70.8M
-143.84%-77.3M
-132.58%-69.95M
2.97%-167.31M
-49.81%-69.88M
16.15%-35.66M
30.12%-31.7M
20.65%-30.08M
-27.66%-172.44M
-41.17%-46.64M
Net non-operating interest income expense
-99.99%-14.77M
-52.58%-14.14M
-65.72%-12.86M
-35.43%-34.09M
-16.43%-9.68M
13.61%-7.39M
-66.82%-9.27M
-181.87%-7.76M
-273.10%-25.17M
-200.29%-8.32M
Non-operating interest income
36.43%3.71M
941.38%3.62M
195.41%4.31M
269.42%7.88M
160.14%3.35M
274.66%2.72M
210.71%348K
20,757.14%1.46M
5,100.00%2.13M
21,350.00%1.29M
Non-operating interest expense
82.88%18.48M
84.75%17.76M
86.26%17.17M
53.70%41.97M
35.69%13.03M
8.95%10.11M
69.67%9.62M
234.07%9.22M
302.25%27.31M
246.02%9.6M
Other net income (expense)
95.94%-8K
-300.00%-6K
-315.00%-43K
-70.91%-188K
84.44%-14K
-1,690.91%-197K
250.00%3K
385.71%20K
94.65%-110K
-429.41%-90K
Other non- operating income (expenses)
95.94%-8K
-300.00%-6K
-315.00%-43K
-70.91%-188K
84.44%-14K
-1,690.91%-197K
250.00%3K
385.71%20K
94.65%-110K
-429.41%-90K
Income before tax
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Income tax
Net income
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Net income continuous Operations
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Minority interest income
Net income attributable to the parent company
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Basic earnings per share
-73.68%-1.32
-85.71%-1.56
-59.55%-1.42
22.18%-3.93
-9.02%-1.45
42.42%-0.76
36.84%-0.84
16.82%-0.89
-29.82%-5.05
-40.00%-1.33
Diluted earnings per share
-73.68%-1.32
-85.71%-1.56
-59.55%-1.42
22.18%-3.93
-9.02%-1.45
42.42%-0.76
36.84%-0.84
16.82%-0.89
-29.82%-5.05
-40.00%-1.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 16.35M7.32M1.91M682K682K00000
Operating revenue --16.35M--7.32M--1.91M--682K--682K--0--0--0--0--0
Cost of revenue 2.36M1.38M426K167K167K0000
Gross profit 14M5.95M1.49M515K515K0000
Operating expense 137.79%84.79M162.60%83.25M137.52%71.44M-2.68%167.83M50.92%70.39M-16.15%35.66M-30.12%31.7M-20.65%30.08M27.66%172.44M41.17%46.64M
Selling and administrative expenses 225.27%76.1M300.65%75.87M233.42%62.01M16.76%117.93M85.68%57M-0.48%23.4M-28.67%18.94M-8.14%18.6M60.98%101M57.51%30.7M
Research and development costs -29.11%8.69M-42.21%7.38M-17.85%9.43M-30.15%49.9M-16.00%13.39M-35.53%12.26M-32.16%12.76M-35.00%11.48M-1.24%71.44M17.67%15.95M
Operating profit -98.54%-70.8M-143.84%-77.3M-132.58%-69.95M2.97%-167.31M-49.81%-69.88M16.15%-35.66M30.12%-31.7M20.65%-30.08M-27.66%-172.44M-41.17%-46.64M
Net non-operating interest income expense -99.99%-14.77M-52.58%-14.14M-65.72%-12.86M-35.43%-34.09M-16.43%-9.68M13.61%-7.39M-66.82%-9.27M-181.87%-7.76M-273.10%-25.17M-200.29%-8.32M
Non-operating interest income 36.43%3.71M941.38%3.62M195.41%4.31M269.42%7.88M160.14%3.35M274.66%2.72M210.71%348K20,757.14%1.46M5,100.00%2.13M21,350.00%1.29M
Non-operating interest expense 82.88%18.48M84.75%17.76M86.26%17.17M53.70%41.97M35.69%13.03M8.95%10.11M69.67%9.62M234.07%9.22M302.25%27.31M246.02%9.6M
Other net income (expense) 95.94%-8K-300.00%-6K-315.00%-43K-70.91%-188K84.44%-14K-1,690.91%-197K250.00%3K385.71%20K94.65%-110K-429.41%-90K
Other non- operating income (expenses) 95.94%-8K-300.00%-6K-315.00%-43K-70.91%-188K84.44%-14K-1,690.91%-197K250.00%3K385.71%20K94.65%-110K-429.41%-90K
Income before tax -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Income tax
Net income -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Net income continuous Operations -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Minority interest income
Net income attributable to the parent company -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Basic earnings per share -73.68%-1.32-85.71%-1.56-59.55%-1.4222.18%-3.93-9.02%-1.4542.42%-0.7636.84%-0.8416.82%-0.89-29.82%-5.05-40.00%-1.33
Diluted earnings per share -73.68%-1.32-85.71%-1.56-59.55%-1.4222.18%-3.93-9.02%-1.4542.42%-0.7636.84%-0.8416.82%-0.89-29.82%-5.05-40.00%-1.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data